These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1310106)

  • 1. Radionuclide hysterosalpingography with technetium-99m-pertechnetate: application and radiation dose to the ovaries.
    Yang KT; Chiang JH; Chen BS; Liang CH; Lee SF; Liao SC
    J Nucl Med; 1992 Feb; 33(2):282-6. PubMed ID: 1310106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radionuclide hysterosalpingography for evaluation of fallopian tube patency.
    McCalley MG; Braunstein P; Stone S; Henderson P; Egbert R
    J Nucl Med; 1985 Aug; 26(8):868-74. PubMed ID: 4032035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indication and clinical application of radionuclide hysterosalpingography using 99mTc-pertechnetate.
    Rýznar V; Heczko P; Husák V; Gazárek F; Pohanka J; Zenísek L; Wiedermann M; Erban J
    Acta Univ Palacki Olomuc Fac Med; 1984; 107():185-93. PubMed ID: 6100765
    [No Abstract]   [Full Text] [Related]  

  • 4. [About the possibility of fallopian tubes patency evaluations by means of 99mTc-pertechnetate and comparison of radiation loads due to radioisotopic and x-ray examinations (author's transl)].
    Rýznar V; Heczko P; Husák V; Gazárek F; Wiedermann M; Erban J; Pohanka J
    Cesk Gynekol; 1981 Nov; 46(9):692-5. PubMed ID: 6272998
    [No Abstract]   [Full Text] [Related]  

  • 5. Radiation exposure of the ovaries during hysterosalpingography. Is radionuclide hysterosalpingography justified?
    van der Weiden RM; van Zijl J
    Br J Obstet Gynaecol; 1989 Apr; 96(4):471-2. PubMed ID: 2751961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation dose from radiopharmaceuticals contaminated with molybdenum-99.
    Shearer DR; Pezzullo JC; Moore MM; Coleman P; Frater SI
    J Nucl Med; 1988 May; 29(5):695-700. PubMed ID: 2836569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dosimetry of a 99mTc-labeled IgM murine antibody to CD15 antigens on human granulocytes.
    Mozley PD; Stubbs JB; Dresel SH; Barraclough ED; Smith T; Patel M; Finkelman C; Sparks RB; Thakur ML; Mathur A; Alavi A
    J Nucl Med; 1999 Apr; 40(4):625-30. PubMed ID: 10210221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Initial experiences with hysterosalpingoscintigraphy in normal and pathologic fallopian tube passage].
    Steck T; Becker W; Albert P; Börner W; Würfel W
    Geburtshilfe Frauenheilkd; 1989 Oct; 49(10):889-93. PubMed ID: 2583431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hysterosalpingoscintigraphy: a simple and accurate method of evaluating fallopian tube patency.
    Becker W; Steck T; Albert P; Börner W
    Nuklearmedizin; 1988 Dec; 27(6):252-7. PubMed ID: 3217255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation dose optimisation and risk estimation to patients and staff during hysterosalpingography.
    Sulieman A; Theodorou K; Vlychou M; Topaltzikis T; Roundas C; Fezoulidis I; Kappas C
    Radiat Prot Dosimetry; 2008; 128(2):217-26. PubMed ID: 17584732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation dosage of the ovaries during hysterosalpingography. Is radionuclide hysterosalpingography justified?
    Kennedy SH; Mojiminiyi OA; Soper ND; Shepstone BJ; Barlow DH
    Br J Obstet Gynaecol; 1989 Nov; 96(11):1359-60. PubMed ID: 2611179
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of source and age of sodium pertechnetate Tc 99m on radiochemical purity of technetium Tc 99m exametazime.
    Millar AM
    Am J Hosp Pharm; 1993 Jan; 50(1):103-6. PubMed ID: 8381258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc.
    Kriehuber R; Kadenbach K; Schultz F; Weiss DG
    Int J Radiat Biol; 2004; 80(11-12):875-80. PubMed ID: 15764396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of radiation dose to patients in hysterosalpingography].
    Calicchia A; Chiacchiararelli L; De Felice C; Gigliotti T; Indovina PL; Mazzei F; Porfiri LM
    Radiol Med; 1998; 95(1-2):93-7. PubMed ID: 9636734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation-dose calculation for five Tc-99m IDA hepatobiliary agents.
    Brown PH; Krishnamurthy GT; Bobba VR; Kingston E; Turner FE
    J Nucl Med; 1982 Nov; 23(11):1025-30. PubMed ID: 6897074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of uterine radiation exposure from lymphoscintigraphy indicates safety of sentinel lymph node biopsy during pregnancy.
    Spanheimer PM; Graham MM; Sugg SL; Scott-Conner CE; Weigel RJ
    Ann Surg Oncol; 2009 May; 16(5):1143-7. PubMed ID: 19267158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective and ovarian dose in PA conventional and rotational 3D hysterosalpingography examinations.
    Efstathopoulos EP; Charalambatou PP; Tsalafoutas IA; Kelekis AD; Antonakos I; Brountzos E; Kelekis DA
    Phys Med; 2013 Sep; 29(5):549-55. PubMed ID: 23517667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation dose reduction during hysterosalpingography: an application of scanning-beam digital radiography.
    Kushner DC; Yoder IC; Cleveland RH; Herman TE; Goodsitt MM
    Radiology; 1986 Oct; 161(1):31-3. PubMed ID: 3763882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Exposure of ovaries to radiation doses during hysterosalpingography].
    Jankowski J; Nowak B; Pertyński T; Bialobrzeski J; Skrabulska A; Joźwiak M
    Pol Tyg Lek; 1976 Dec; 31(49):2103-4. PubMed ID: 1034295
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of radiation dose to infants from breast milk following the administration of 99mTc pertechnetate to nursing mothers.
    Ogunleye OT
    Health Phys; 1983 Jul; 45(1):149-51. PubMed ID: 6307926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.